Notice of Annual General Meeting
Awaiting price reaction for this filing.
Murae Organisor Limited (formerly Earum Pharmaceuticals Limited) has filed the notice for its 13th Annual General Meeting to be held on Tuesday, 30th September 2025 at 1:00 PM via video conferencing. Shareholders will consider adoption of the audited financial statements for FY 2024-25 and re-appointment of Mr. Nitinkumar Ashokkumar Tomar, who retires by rotation. The meeting also seeks approval to appoint M/s. S Parth & Co. as statutory auditor and M/s. Jay Pandya & Associates as secretarial auditor, each for a five-year term (FY 2025-26 to FY 2029-30). Three independent directors — Mr. Ankit Patel, Mr. Mayur Sureshkumar Vyas, and Ms. Vaishaliben Patel — are proposed for regularization for five-year terms, and Mr. Chinmay Shrikant Pradhan is proposed as Managing Director with remuneration up to Rs. 2 lakh per month. Additionally, Mr. Nitinkumar Ashokkumar Tomar's designation changes from Managing Director cum Chairperson to Non-Executive Non-Independent Director cum Chairperson, effective 29th March 2025. E-voting will be facilitated by NSDL, with the cut-off date set as 23rd September 2025.
This is a routine AGM covering director appointments, auditor re-appointments, and financial statement adoption, with no dividend or major capital action announced. The leadership reshuffle — a new Managing Director and a shift of the previous MD to a non-executive chair role — is the main governance change for shareholders to note, but is unlikely to materially impact the stock price in the near term.